COVID-19 Policy

 

NAPPN Latest COVID Guidance 

Conferences are currently taking place successfully across the United States, welcoming domestic and international audiences as we all enjoy the return to live events.

We are working closely with our partners and host venue to implement simple safety measures so that everyone can enjoy the valuable networking and business mingling that are such a vital part of our live event experience.

At the conference:

  • Fully vaccinated – All attendees must be fully vaccinated against Covid-19, including a booster dose at least two weeks before the event, if the previous vaccine was more than 6 months prior to the event. Negative test results are also acceptable in lieu of the above.

  • Wear a mask – Masking will be highly suggested indoors.

  • Stay home if you feel unwell – Do not attend if you are displaying symptoms, test positive, or are required to self-isolate.

  • Be mindful of others – Everyone has their own personal comfort level re proximity and contact, so give each other space.

  • Practice hand hygiene – Sanitizers and washrooms will be available throughout the venue.

  • We are providing transferrable registrations and the choice to switch from in-person to virtual registration with a refund of the difference for the 2023 Annual Meeting if you are sick and cannot travel.

Traveling to the United States:

If you are traveling to the US, please check the latest travel requirements:

www.cdc.gov/coronavirus/2019-ncov/travelers/noncitizens-US-air-travel.html


Contact Us

If you need support with any other questions relating to your attendance, contact us at DanforthEvents@danforthcenter.org

 

The safety of our attendees is our highest priority

Additional Information

 

Centers for Disease Control and Prevention (CDC)
https://www.cdc.gov/coronavirus/2019-nCoV/index.html

World Health Organization (WHO)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019

World Health Organization (WHO) - COVID-19 Vaccines
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines